CA Stock MarketDetailed Quotes
PRM Big Pharma Split Corp
- 13.350
- +0.240+1.83%
15min DelayTrading Nov 26 11:51 ET
15.09MMarket Cap13.48P/E (TTM)
13.400High13.350Low500Volume13.400Open13.110Pre Close6.68KTurnover14.57752wk High0.04%Turnover Ratio1.13MShares12.21052wk Low0.99EPS TTM15.09MFloat Cap14.577Historical HighLossP/E (Static)1.13MShs Float5.080Historical Low-0.53EPS LYR0.38%Amplitude1.24Dividend TTM0.95P/B1Lot Size9.27%Div YieldTTM
Big Pharma Split Corp Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash flow from continuing operating activities | 1.27M | ||||||
| Net income from continuing operations | -127.01%-645.35K | -43.24%2.39M | 2,036.51%4.21M | -108.43%-217.39K | 22.57%2.58M | 761.50%2.1M | ---318.2K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | --931.04K | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---4.09M | ---- |
| Other non cashItems | 48.98%-2.12K | 98.21%-4.16K | ---231.53K | ---- | ---- | --2.38M | ---- |
| Change in working capital | -94.49%9.66K | 213.67%175.39K | -386.97%-154.29K | -951.93%-31.68K | 94.42%-3.01K | -199.72%-53.96K | --54.11K |
| -Change in other current liabilities | -94.49%9.66K | 213.67%175.39K | -386.97%-154.29K | -951.93%-31.68K | ---3.01K | ---- | --54.11K |
| Cash from discontinued operating activities | |||||||
| Operating cash flow | 950.88%11.86M | 112.54%1.13M | -306.98%-9M | -49.90%4.35M | 583.04%8.68M | 104.11%1.27M | ---30.95M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | |||||||
| Cash from discontinued investing activities | |||||||
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -2.71M | ||||||
| Net commonstock issuance | -1,431.26%-5.32M | -94.72%399.78K | 549.06%7.57M | 53.89%-1.69M | -1,280.08%-3.66M | -101.30%-265.09K | --20.4M |
| Net preferred stock issuance | -1,147.51%-5.04M | -91.63%481.16K | 565.60%5.75M | 56.34%-1.23M | -1,380.17%-2.83M | -101.40%-191K | --13.6M |
| Cash dividends paid | 19.39%-2.11M | 7.76%-2.62M | -63.83%-2.84M | 16.93%-1.73M | 7.53%-2.08M | ---2.25M | --0 |
| Net other financing activities | --0 | --0 | --0 | --0 | --0 | ---- | --0 |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -617.83%-12.47M | -117.04%-1.74M | 319.13%10.19M | 45.71%-4.65M | -216.27%-8.57M | -108.28%-2.71M | --32.74M |
| Net cash flow | |||||||
| Beginning cash position | -42.71%819.21K | 518.99%1.43M | -56.91%230.99K | 28.53%536.06K | -77.40%417.07K | --1.85M | --0 |
| Current changes in cash | -0.58%-612.38K | -151.02%-608.87K | 493.10%1.19M | -376.37%-303.61K | 107.64%109.86K | -180.79%-1.44M | --1.78M |
| Effect of exchange rate changes | -51.61%-2.64K | -132.49%-1.74K | 467.60%5.36K | -115.96%-1.46K | -12.12%9.13K | -83.89%10.39K | --64.48K |
| End cash position | -75.07%204.19K | -42.71%819.21K | 518.99%1.43M | -56.91%230.99K | 28.53%536.06K | -77.40%417.07K | --1.85M |
| Free cash from | 950.88%11.86M | 112.54%1.13M | -306.98%-9M | -49.90%4.35M | 583.04%8.68M | 104.11%1.27M | ---30.95M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data